{
  "report_rows": [
    {
      "kpi": "Adjusted EBITDA",
      "prediction": "BEAT",
      "answer": "pred ~$1.30B vs. cons $1.27B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$1.86 vs. cons $1.83",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Free cash flow before growth investments",
      "prediction": "BEAT",
      "answer": "pred ~$0.72B vs. cons $0.68B",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Adjusted EBITDA guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~$5.575B vs. cons $5.549B (FY2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "Adjusted EPS guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~$8.90 vs. cons $8.85 (FY2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "Free cash flow before growth investments guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~$3.05B vs. cons $3.05B (FY2026)",
      "confidence": "HIGH"
    }
  ],
  "day1_residual_pct": 3.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 1.8,
  "day5_path": "FADE",
  "day5_rationale": "A modest operating and cash-flow beat should initially reward the reset valuation, but unchanged FY2026 guidance implies limited upward revision to $5.55B EBITDA and $8.85 EPS consensus; stronger Q2 results mainly reduce the implied second-half requirement rather than raise out-period estimates.",
  "day5_confidence": "MEDIUM"
}